Affiliations 

  • 1 Chulalongkorn Centre of Excellence for Parkinson's Disease and Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, 10330, Thailand. Electronic address: rbh@chulapd.org
  • 2 Chulalongkorn Centre of Excellence for Parkinson's Disease and Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, 10330, Thailand
  • 3 Department of Neurosurgery, University Medical Centre Goettingen, Paracelsus-Elena Hospital, Kassel, Germany
  • 4 Movement Disorder Centre at Seoul National University Hospital, Seoul, South Korea
  • 5 Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan
  • 6 Department of Neurology, Chang-Gung Memorial Hospital, Linkou Medical Centre and Chang-Gung University College of Medicine, Taipei, Taiwan
  • 7 Movement Disorder Centre, Centre Hospitalier Universitaire (CHU) of Grenoble, Grenoble Alpes University, INSERM U1216, France
  • 8 Division of Neurology, Department of Medicine and the Mah Pooi Soo and Tan Chin Nam Centre for Parkinson's and Related Disorders, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
  • 9 Department of Neurology, West China Hospital, Sichuan University, China
  • 10 Neuroscience Institute, Department of Neurology and Psychiatry, University of Santo Tomas Hospital, Manila, Philippines
  • 11 Department of Neurology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center & Seoul National University College of Medicine, Seoul, South Korea
  • 12 Department of Neurology, University of Medicine, Yangon General Hospital, Yangon, Myanmar
  • 13 National Neuroscience Institute, DUKE NUS Medical School, Singapore
  • 14 Department of Neurology, Island Hospital, Penang, Malaysia
  • 15 Movement Disorder Unit, Neurology Department, University Medical Centre, Ho Chi Minh City University of Medicine and Pharmacy, Ho Chi Minh, Viet Nam
  • 16 Department of Neurology, Hanoi Medical University and National Geriatric Hospital, Hanoi, Viet Nam
  • 17 University of Health Science, Vientiane, Laos
  • 18 Chulalongkorn Parkinson Patients' Support Group, Chulalongkorn Centre of Excellence for Parkinson's Disease and Related Disorders, Bangkok, Thailand
  • 19 Center for Neurorestoration, Cleveland Clinic, Cleveland, OH, USA
Parkinsonism Relat Disord, 2020 03;72:82-87.
PMID: 32146380 DOI: 10.1016/j.parkreldis.2020.02.013

Abstract

An international panel of movement disorders specialists explored the views and perceptions of people with Parkinson's disease (PD) about their condition and its treatment, including the potential mismatch between the clinician's view of the patient's condition and their own view of what aspects of the disease most affect their daily lives. The initiative was focused on Asian countries, so participants comprised experts in the management of PD from key centers in Asia, with additional insight provided by European and the North American movement disorders experts. Analysis of peer-reviewed publications on patient perceptions of PD and the factors that they consider important to their wellbeing identified several contributing factors to the mismatch of views, including gaps in knowledge of PD and its treatment, an understanding of the clinical heterogeneity of PD, and the importance of a multidisciplinary approach to patient care. The faculty proposed options to bridge these gaps to ensure that PD patients receive the personalized treatment they need to achieve the best possible outcomes. It was considered essential to improve patient knowledge about PD and its treatment, as well as increasing the awareness of clinicians of PD heterogeneity in presentation and treatment response. A multidisciplinary and shared-care approach to PD was needed alongside the use of patient-centered outcome measures in clinical trials and clinical practice to better capture the patient experience and improve the delivery of individualized therapy.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.